Search clinical trials for: GnRH Antagonist Protocol

Total 40153 results

IVI Madrid

Completed

Oral Contraceptive Pill and GnRH Antagonist Versus Long Protocol in IVF Patients (Larganta)

Infertility

Spain
Johns Hopkins University

Withdrawn

Endometrial Luteal Phase Characteristics and Luteal Phase Support in Controlled Ovarian Stimulation Protocols With GnRH Antagonists:Focusing on MicroRNA

Controlled Ovarian Stimulation

United States
Shin Kong Wu Ho-Su Memorial Hospital

Unknown

Corifollitropin Alfa Application in PCOS Patients

In Vitro Fertilization

Taiwan
Bioroma

Unknown

Clomiphene Citrate Plus Gonadotropins and GnRH Antagonist Versus Flexible GnRH Antagonist Protocol Versus Microdose GnRH Agonist Protocol in Poor Responders Undergoing IVF

GnRH Antagonist | IVF | Poor Responders | Clomiphene Citrate | GnRH Agonist

Italy
Sheba Medical Center

Unknown

Ultrashort GnRH Agonist/Antagonist Versus GnRH Antagonist IVF

Infertility

Israel
Bioroma

Unknown

Long Acting FSH Plus Antagonist Versus Daily FSH Plus Antagonist Versus Short Agonist Protocol in Poor Responders Undergoing IVF

Female Infertility | Poor Responder

Italy
Pınar Özcan Cenksoy

Unknown

The Comparison of Effect of Four Different Treatment Protocols on IVF Outcomes in Poor Responders Undergoing in Vitro Fertilization.

Poor Responders Undergoing IVF
Eugonia

Completed

Flexible GnRH Antagonist vs Flare up GnRH Agonist Protocol in Poor Responders

Infertility | Premature Ovarian Failure

Greece
Hospital de Clinicas de Porto Alegre

Unknown

Evaluation of Granulosa Cells Function After IVF Protocols

Infertility | In Vitro Fertilization Protocols

Brazil
Huang Rui

Unknown

Comparison of Ovarian Mild Stimulation and Controlled Ovarian Stimulation in Poor Ovarian Responders (POR)

Infertility

China
Universitair Ziekenhuis Brussel

Completed

Preimplantation Genetic Diagnosis (PGD) With Gonadotropin-releasing Hormone (GnRH) Agonist Versus Antagonist (Avanti)

Fertility | Reproductive Endocrinology | Optimal Stimulation Protocol

Belgium
Institut Universitari Dexeus

Terminated

Polycystic Ovary Syndrome (PCOS) and In Vitro Fertilization (IVF): A Comparison Between Standard Long Protocol Versus an Antagonist Protocol Starting on Day 1

Polycystic Ovary Syndrome | In Vitro Fertilization

Spain
European Hospital

Unknown

The Results of Preimplantation Genetic Diagnosis and Preimplantation Genetic Screening of Embryos Obtained From GnRH-agonist Long and GnRH-antagonist Ovarian Stimulation Protocol

Embryo's Genetic and Chromosomal Quality

Italy
Bulent Haydardedeoglu

Terminated

In Vitro Fertilization Outcomes of Two Treatment Protocols in Women With Polycystic Ovary Syndrome (PCOS and ivf)

PCOS GnRH Antagonist and GnRH Agonist IVF/ICSI Cycles

Turkey
Gemer

Completed

Estrogen Pretreatment Prior to GnRH Antagonist Protocol

Infertility

France
Cairo University
Ahmed Elgazzar Hospital

Completed

Extended High Dose Letrozole Regimen Versus Short Low Dose Letrozole Regimen as an Adjuvant to GnRH Antagonist Protocol in the Management of Poor Responders Undergoing IVF-ET

Infertility

Egypt
Instituto Valenciano de Infertilidad, IVI VALENCIA

Completed

GnRH Agonist and Antagonists in an Oocyte Donation Program

Effect of Two Protocols of Ovarian Stimulation on Oocyte Quality

Spain
Clinic and Research Center in Human Reproduction...

Completed

Pregnancy Outcomes With a GnRH Antagonist Protocol Versus GnRH-Agonist Protocol in ICSI Cycles

Infertility

Brazil
Eugonia

Unknown

Comparison Between GnRH Agonist and GnRH Antagonist Protocols of Ovarian Stimulation in PCOS Patients

Polycystic Ovary Syndrome | Ovarian Hyperstimulation Syndrome

Greece
Eugonia

Unknown

Comparison of the Long GnRH Agonist Protocol and the Flexible GnRH Antagonist Protocol of Ovarian Stimulation

Infertility

Greece
University of Melbourne
Monash University; University of Adelaide; University of Sydney; The University... and other collaborators

Not yet recruiting

PLatform for Adaptive Trials In Perinatal UnitS - [Core Protocol] (PLATIPUS)

Preterm Birth
Memorial Sloan Kettering Cancer Center
TransThera Sciences

Recruiting

A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer

Prostate Cancer

United States
Children's National Research Institute

Not yet recruiting

Dexamethasone Use in Pediatric Rhabdomyolysis Patients in Addition to Standard Protocols

Rhabdomyolysis

United States
Howard University
National Institute on Drug Abuse (NIDA); University of Miami; University of Illinois... and other collaborators

Not yet recruiting

Integrating MOUD in African American Community Settings (Better Together)

Opioid Use Disorder

United States
Memorial Sloan Kettering Cancer Center
Verastem, Inc.

Recruiting

A Study of Avutometinib, Defactinib, and Letrozole in People With Low-Grade Serous Ovarian Cancer (CHAMELEON)

Low-Grade Serous Ovarian Cancer

United States
Xiaojun Chen

Recruiting

GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Atypical Hyperplasia Patients

Obesity | Atypical Endometrial Hyperplasia | Progesterone Resistance

China
Xiaojun Chen

Recruiting

GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Cancer Patients

Obesity | Atypical Endometrial Hyperplasia | Endometrial Neoplasms | Progesterone Resistance

China
Novartis Pharmaceuticals

Not yet recruiting

NEPC Study: An Exploratory Safety and Efficacy Study With PSMA, SSTR2 and GRPR Targeted Radioligand Therapy in Metastatic Neuroendocrine Prostate Cancer.

Metastatic Neuroendocrine Prostate Cancer
University of Wisconsin, Madison

Not yet recruiting

Ketamine-assisted Psychotherapy for Adolescent PTSD (KAP)

Posttraumatic Stress Disorder

United States
Mỹ Đức Hospital

Recruiting

PPOS vs GnRH Antagonist in Ovarian Stimulation (ProGanOS Study) (ProGanOS)

Progestins Primed Ovarian Stimulation

Vietnam
Yale University
Johns Hopkins University; University of Colorado, Denver; Northwestern University and other collaborators

Recruiting

Pre-IVF Treatment With a GnRH Antagonist in Women With endometriosis_temp (PREGnant)

Infertility | Endometriosis

United States
Mayo Clinic

Recruiting

Risk Stratified De-escalated Hormone Therapy With Radiation Therapy for the Treatment Prostate Cancer

Prostate Adenocarcinoma | Oligometastatic Prostate Carcinoma

United States
International Research Training Group 2804
German Research Foundation; Uppsala University; University Hospital Tuebingen

Not yet recruiting

Breast Cancer & Antiestrogenic Therapy & Brain

Menopause | Breast Cancer Female | Healthy Female | Anti-estrogenic Therapy

Germany
Amgen

Recruiting

AMG 193 Alone or in Combination With Other Therapies in Subjects With Advanced Thoracic Tumors With Homozygous MTAP-deletion (Master Protocol)

Non-small Cell Lung Cancer | Thoracic Tumors

United States
Memorial Sloan Kettering Cancer Center
Evergreen Theragnostics; Recordati Pharmaceutical company

Recruiting

A Study of Pasireotide in People With Prolactinoma

Prolactin-Producing Pituitary Tumor

United States
University of Colorado, Denver
National Institute on Aging (NIA)

Recruiting

Cardiometabolic Consequences of the Loss of Ovarian Function (LILAC)

Menopause | Aging | Adiposity | Estrogen Deficiency

United States
University of Wisconsin, Madison
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Brain Blood Flow Responses to Stress: Sex Differences

Cerebrovascular Disorders

United States
University of Wisconsin, Madison

Not yet recruiting

High Confusion: Cannabis & Driving

Impairment, Cognitive | Impairment of Attention | Impairment, Psychomotor
VA Office of Research and Development

Not yet recruiting

Ketamine for Veterans With Parkinson's Disease (KPD)

Parkinson?s Disease

United States
Bedaya Hospital

Not yet recruiting

Dydrogesterone Versus GnRH Antagonist in Poor Responders Undergoing Double Ovarian Stimulation

Infertility

Egypt
Yizhuo Zhang

Recruiting

Ondansetron (ODF) Versus Ondansetron Intravenously for the Prevention of Chemotherapy-induced Nausea and Vomiting Compare in Children

Pediatric Solid Tumor, Unspecified, Protocol Specific

China
University of Washington
Breast Cancer Research Foundation

Not yet recruiting

Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer

Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Metastatic HER2-Negative Breast Carcinoma | Metastatic Hormone Receptor-Positive Breast Carcinoma | Locally Advanced Unresectable HER2-Negative Breast Carcinoma | Locally Advanced Unresectable Hormone Receptor-Positive...

United States
PETHEMA Foundation

Not yet recruiting

Treatment Protocol for Newky Diagnosed Adult Ph Positive ALL (LALPh2022)

Lymphoblastic Leukemia | Adult ALL | Philadelphia-Positive ALL
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Luteal Phase Support With GnRH Agonist After GnRH Agonist Triggering in IVF/ICSI Cycles (SOLOAGO)

In Vitro Fertilization | ICSI Intracytoplasmic Spermatozoid Injection

France
Embryolab Fertility Clinic
ART Fertility Clinics LLC

Recruiting

The Effect of Dual Trigger (GnRH Agonist + hCG) for Final Maturation in Oocyte Donors With History of a Previous Cycle With Suboptimal Response to GnRH Agonist Only Trigger

Ovarian Stimulation | Oocyte Donors | Human Chorionic Gonadotropin

Greece
Memorial Sloan Kettering Cancer Center
Merck Sharp & Dohme LLC

Recruiting

A Study of Lenvatinib, Pembrolizumab, and Fulvestrant in People With Breast Cancer

Metastatic Breast Cancer

United States
Yale University
Pfizer

Recruiting

The SUGAR Study: (SBRT and Ultrashort GnRH Antagonist-Relugolix) for Clinicogenomic Unfavorable Intermediate Risk Prostate Cancer

Prostate Cancer

United States
Memorial Sloan Kettering Cancer Center
Astellas Pharma US, Inc.; Corcept Therapeutics; Breast Cancer Research Foundation

Recruiting

A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer

Metastatic Breast Cancer

United States
University of Wisconsin, Madison
National Cancer Institute (NCI)

Recruiting

Study of 18F-FFNP Breast PET/MRI

Breast Cancer

United States
Memorial Sloan Kettering Cancer Center
Janssen Pharmaceuticals

Recruiting

A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)

Multiple Myeloma | Monoclonal Gammopathy of Renal Significance

United States

Search clinical trials for: GnRH Antagonist Protocol

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ireland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations